ctrl K

Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

13.54

-0.17 (-1.24%)

At close: May 01, 2025, 3:59 PM

14.20

4.84%

After-hours: May 01, 2025, 06:51 PM EDT

Centessa Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	6.85M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	130.92K	33.99K	n/a	n/a
Gross Profit	n/a	6.85M	-130.92K	-33.99K	n/a	n/a
Operating Income	-201.06M	-171.28M	-212.26M	-139.31M	-10.44M	-5.05M
Interest Income	14.02M	10.48M	7.03K	2.55K	378.00	5K
Pretax Income	-232.91M	-176.14M	-216.95M	-381.74M	-10.66M	-5.06M
Net Income	-235.76M	-151.09M	-216.21M	-381.85M	-11.04M	-5.28M
Selling & General & Admin	50.81M	53.73M	55.2M	42.97M	1.14M	790K
Research & Development	150.24M	124.41M	155.08M	96.31M	9.3M	4.26M
Other Expenses	n/a	n/a	2.34M	n/a	155K	105K
Operating Expenses	201.06M	178.14M	210.28M	139.28M	10.44M	5.05M
Interest Expense	-10.08M	9.91M	7.03M	2.55M	378K	118K
Selling & Marketing Expenses	n/a	n/a	n/a	42.93M	n/a	n/a
Cost & Expenses	n/a	178.14M	210.28M	139.31M	10.44M	5.05M
Income Tax Expense	2.84M	-25.06M	-747K	113.99K	378K	223K
Shares Outstanding (Basic)	114.47M	96.18M	93.4M	89.99M	142.06M	70.89M
Shares Outstanding (Diluted)	114.47M	96.18M	93.4M	89.99M	142.06M	70.89M
EPS (Basic)	-2.06	-1.57	-2.31	-4.24	-0.08	-0.07
EPS (Diluted)	-2.06	-1.57	-2.31	-4.24	-0.08	-0.07
EBITDA	-201.06M	-166.07M	-212.26M	-379.16M	-10.43M	-4.94M
EBIT	-243M	-166.24M	-209.79M	-139.33M	-10.44M	-5.05M
Depreciation & Amortization	942.4K	813.14K	130.92K	33.99K	6K	6K